The Interleukin-8 (IL-8/CXCL8) Receptor Inhibitor Reparixin Improves Neurological Deficits and Reduces Long-term Inflammation in Permanent and Transient Cerebral Ischemia in Rats

Table 2 Quantification of glial reaction in transient MCAO

Treatment	GFAP	CD11b
Vehicle	46.5 ± 3.0	59.2 ±5.7
Reparixin	17.6 ± 1.6**	22.7 ± 1.0**

^aData are expressed as the percentage of immunopositive area (see Figure 6 for representative pictures and experimental details) in the ischemic hemisphere and are the mean ± SE of 3 rats for each group. Ten serial sections for each animal were analyzed for each marker. **P < 0.01 by Student t-test.

ISSN: 1528-3658